ZA955031B - Treatment of nicotine craving and/or smoking withdrawal symptoms - Google Patents

Treatment of nicotine craving and/or smoking withdrawal symptoms

Info

Publication number
ZA955031B
ZA955031B ZA955031A ZA955031A ZA955031B ZA 955031 B ZA955031 B ZA 955031B ZA 955031 A ZA955031 A ZA 955031A ZA 955031 A ZA955031 A ZA 955031A ZA 955031 B ZA955031 B ZA 955031B
Authority
ZA
South Africa
Prior art keywords
treatment
withdrawal symptoms
nicotine craving
smoking withdrawal
smoking
Prior art date
Application number
ZA955031A
Inventor
Satyanarayana Majeti
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of ZA955031B publication Critical patent/ZA955031B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058Chewing gums
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA955031A 1994-06-23 1995-06-19 Treatment of nicotine craving and/or smoking withdrawal symptoms ZA955031B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26455494A 1994-06-23 1994-06-23

Publications (1)

Publication Number Publication Date
ZA955031B true ZA955031B (en) 1996-02-08

Family

ID=23006582

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA955031A ZA955031B (en) 1994-06-23 1995-06-19 Treatment of nicotine craving and/or smoking withdrawal symptoms

Country Status (6)

Country Link
AU (1) AU2770895A (en)
IL (1) IL114128A0 (en)
MA (1) MA23587A1 (en)
PE (1) PE41096A1 (en)
WO (1) WO1996000070A1 (en)
ZA (1) ZA955031B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0828489A4 (en) * 1996-03-13 2001-04-04 Univ Yale Smoking cessation treatments using naltrexone and related compounds
WO1997034605A1 (en) * 1996-03-21 1997-09-25 Mayo Foundation For Medical Education And Research Use of nicotine to treat liver disease
JP3707798B2 (en) * 1996-05-13 2005-10-19 ノバルティス・コンシューマー・ヘルス・ソシエテ・アノニム Intraoral drug delivery system
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US6165516A (en) * 1996-11-27 2000-12-26 Wm. Wrigley Jr. Company Method of controlling release of caffeine in chewing gum
CA2369515A1 (en) 1999-04-06 2001-03-29 Wm. Wrigley Jr. Company Pharmaceutical chewing gum formulations
DE20018196U1 (en) 2000-10-25 2001-01-11 Peter, Michael N., 22297 Hamburg Confectionery product for smoking cessation
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
WO2004104490A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Self-contained heating unit and drug-supply unit employing same
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
AU2004289248B2 (en) 2003-11-07 2012-05-03 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
WO2008112661A2 (en) 2007-03-09 2008-09-18 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
WO2012083947A1 (en) * 2010-12-21 2012-06-28 Fertin Pharma A/S Chewing gum composition comprising cross-linked polyacrylic acid
JP2023540184A (en) * 2020-09-03 2023-09-22 ニコベンチャーズ トレーディング リミテッド Compositions and methods
CN115590855A (en) * 2022-10-26 2023-01-13 江南大学(Cn) Method for reducing nicotine content in nicotine product

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617418C3 (en) * 1967-12-16 1980-01-24 Hoechst Ag, 6000 Frankfurt Manufacture of solid drug forms with delayed release of active ingredients
DE1901277A1 (en) * 1969-01-10 1970-08-06 Partipharm Ag Chewing gum to com ensate for excessive - cigarette smoking
US4778677A (en) * 1981-07-09 1988-10-18 Ebbesen Gerald K Method for treatment of nicotine craving
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3506406A1 (en) * 1985-02-23 1986-08-28 Hans-Josef 5600 Wuppertal Stromberg DEVICE FOR THE DEWNING OF EATING, DRINKING, SMOKING AND / OR ADDICTIVE Habits
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
DK365389D0 (en) * 1989-07-24 1989-07-24 Fertin Lab As ANTIFUNGAL CHEMICAL GUM PREPARATION
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency
FI913526A (en) * 1990-08-23 1992-02-24 Wrigley W M Jun Co TUGGUMMI MED LAOG FUKTHALT.

Also Published As

Publication number Publication date
IL114128A0 (en) 1995-10-31
MA23587A1 (en) 1995-12-31
WO1996000070A1 (en) 1996-01-04
AU2770895A (en) 1996-01-19
PE41096A1 (en) 1996-10-08

Similar Documents

Publication Publication Date Title
AU2703795A (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
ZA955031B (en) Treatment of nicotine craving and/or smoking withdrawal symptoms
PL318153A1 (en) Smoking article and cigarette of low co content
AP2000001736A0 (en) Method of treating tobacco to reduce nitrosamine content and produced therapy
EP0713655A3 (en) Cigarette substitute article and method of making the same
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
EP0954303A4 (en) Methods of treating mental diseases, inflammation and pain
EP0366982A3 (en) Selective delivery and retention of nicotine by-product from cigarette smoke
EP0836508A4 (en) Dual-lumen catheter and method of use
ZA886603B (en) Cigarette filter rods and cigarettes incorporating such filter rods
ZA955032B (en) Treatment of nicotine craving and/or smoking withdrawal symptoms
EP0632968A3 (en) Filtertow and process for its manufacture and tobacco smoke filter and process for its manufacture.
GB9306107D0 (en) Method of and machine for waking filters for tobacco smoke
ZA955033B (en) Treatment of nicotine craving and/or smoking withdrawal symptoms
GB9410482D0 (en) Tobacco smokers' mouthpiece
AU8096094A (en) Use of nicotine substitutes for the treatment of nicotine withdrawal
AU3879789A (en) Use of benzo(g)quinolines in treatment of nicotine addiction
AU2446895A (en) Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers
EP0443452A3 (en) One-side roughened rolled plane body and production thereof
ZA959717B (en) Tobacco rod and/or filter for smoking article
Bosman Acute effects of transdermal nicotine on EEG and mood during short-term smoking deprivation.
EP0696055A3 (en) Electronic assemblies and methods of treatment
AU607214C (en) Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method
IL110749A0 (en) Smoker's device for reducing the consumption of cigarettes
GB2256573B (en) Method of storing cigarettes or cigars